Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.

作者信息

Azad Rajvardhan, Chandra Parijat

出版信息

Indian J Ophthalmol. 2007 Jul-Aug;55(4):319; author reply 320. doi: 10.4103/0301-4738.33057.

DOI:10.4103/0301-4738.33057

PMID:17595491

Abstract

摘要

相似文献

Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.

Indian J Ophthalmol. 2007 Jul-Aug;55(4):319; author reply 320. doi: 10.4103/0301-4738.33057.

Off-label use of bevacizumab in retinopathy of prematurity.

Retina. 2009 Feb;29(2):284; author reply 284-5. doi: 10.1097/IAE.0b013e31818a1ee7.

Intravitreal bevacizumab (Avastin) for post-laser photocoagulation anterior segment ischemia in aggressive posterior retinopathy of prematurity.

Indian J Ophthalmol. 2007 Jul-Aug;55(4):317; author reply 317-8. doi: 10.4103/0301-4738.33053.

Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.

Ophthalmic Surg Lasers Imaging. 2007 May-Jun;38(3):233-7. doi: 10.3928/15428877-20070501-09.

Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.

Arch Ophthalmol. 2008 Aug;126(8):1161-3. doi: 10.1001/archophthalmol.2008.1.

A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination.

Br J Ophthalmol. 2010 Aug;94(8):1107-9. doi: 10.1136/bjo.2009.162156. Epub 2010 Jun 16.

Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity.

J AAPOS. 2010 Feb;14(1):6-10. doi: 10.1016/j.jaapos.2009.10.011.

Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

Retina. 2009 Apr;29(4):562. doi: 10.1097/IAE.0b013e31819a98a9.

Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

Retina. 2009 Apr;29(4):564-5; author reply 565-8. doi: 10.1097/IAE.0b013e31819bac74.

Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment.

Arch Ophthalmol. 2010 Aug;128(8):1080-1. doi: 10.1001/archophthalmol.2010.145.

引用本文的文献

Survey of intravitreal injection techniques among retina specialists in Israel.

Clin Ophthalmol. 2016 Jun 14;10:1111-6. doi: 10.2147/OPTH.S96452. eCollection 2016.

Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease.

BMC Ophthalmol. 2015 Mar 8;15:20. doi: 10.1186/s12886-015-0001-7.

Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.

J Pers Med. 2013;3(1):40-69. doi: 10.3390/jpm3010040.

Changing paradigms of anti-VEGF in the Indian scenario.

Indian J Ophthalmol. 2014 Jan;62(1):88-92. doi: 10.4103/0301-4738.126189.

Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity.

Br J Ophthalmol. 2014 Apr;98(4):507-12. doi: 10.1136/bjophthalmol-2013-304109. Epub 2014 Jan 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验